Running Interference: RNAi with Silence Therapeutics' Craig Tooman
Business Of Biotech
00:00
The Next Big Project, Silence
Silence Therapeutics CEO Craig Cragg talks about his company and its new project. He says the next chapter of silence's story will be anything but silent. Andi hope that, you know, were able to kind of help you maintain your position on that radar here in the states.
Transcript
Play full episode
